|
Arbor Research to present findings at ASN Kidney Week
Arbor Research is proud to present 17 abstracts, including three oral presentations, at the American Society of Nephrology's Kidney Week in San Diego, October 30 through November 4, 2012. Please click here for a complete schedule of our presentations.
|
|
Job Openings
As we continue to grow, we are look-ing to build a diverse and dynamic staff who can help us address the pressing health-care challenges of today and tomorrow.
Network Administrator
Research Analyst
Research Scientist
Project Coordinator
|
|
|
Greetings!
Welcome to the October issue of the Arbor Research quarterly newsletter. We've updated the look of this newsletter to match our newly redesigned website. You can learn even more about our projects, publications, and capabilities by visiting www.ArborResearch.org. We welcome your feedback! |
|
 Arbor Research awarded NIH grant to study lower urinary tract dysfunction Arbor Research was awarded a grant to study symptoms of lower urinary tract dysfunction (LUTD) under a consortium arrangement named the Lower Urinary Tract Dysfunction Research Network (LURN). This cooperative study will be conducted in conjunction with scientists from the National Institutes of Health and clinical collaborators across the country. It adds a new data coordinating center (DCC) to the Arbor Research portfolio that already supports the A2ALL and RELIVE studies. Click here to learn more... |
 RELIVE study expanded; new grant funded The scope of the RELIVE Living Kidney Donor Study will be expanded under a two-year grant awarded to Arbor Research by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Arbor Research has played a key role in RELIVE for the past several years under a University of Michigan subcontract. The new grant, which runs through August 2014, was awarded directly to Arbor Research. Click here to read more... |
 CKDopps in Brazil
Dr. Bruce Robinson, vice president of research at Arbor Research and principal investigator of the Dialysis Outcomes and Practice Patterns Study (DOPPS), traveled to Sao Paulo to present a symposium at the Brazilian Congress of Nephrology on September 7, 2012. He was joined by members of the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) Brazil Steering Committee for this session, which provided an overview of the DOPPS and CKDopps, findings on hemodialysis practices associated with best patient outcomes, a presentation on chronic kidney disease care in Brazil, and an introduction to CKDopps in the country. Click here to read more...
|
|
Dr. Marc Turenne, a research scientist with Arbor Research, gave a talk titled, "Framing the Issue: Hospital Readmissions in End-Stage Renal Disease," at the ESRD Network Forum Quality Conference on September 11, 2012. The theme of this two-day conference was "Creating a Culture of Quality: Pursuing Excellence in Care Transitions, Enhancing Safety in Kidney Patient Care." Dr. Turenne motivated and informed subsequent discussions at the conference, which was focused on the potential for improving care transitions among dialysis patients, especially transitions occurring between hospitals and dialysis facilities. Dr. Turenne provided background regarding recent attention on hospital readmission as a policy issue, with implications for both quality and cost of care. He also described some of the work conducted by Arbor Research as part of the Quality Measures project for the Centers for Medicare & Medicaid Services on the frequency and causes of readmissions among dialysis patients and the potential influence of both dialysis providers and hospitals in preventing readmissions in end-stage renal disease.
|
|
Recent Publications
Blood pressure levels and mortality risk among hemodialysis patients in the DOPPS.
Hemoglobin A1c levels and mortality in the diabetic hemodialysis population: Findings from the DOPPS. S Ramirez et al. Diabetes Care, 2012.
The DOPPS Practice Monitor for US Dialysis Care: Trends through August 2011. R Pisoni et al. American Journal of Kidney Diseases, 2012.
Utilization of kidneys with similar kidney donor risk values from standard versus expanded criteria donors. K Woodside et al. American Journal of Transplantation, 2012.
A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. G Everson et al. Hepatology, 2012.
Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality. S Ramirez et al. Clinical Journal of the American Society of Nephrology, 2012.
Reduced survival and quality of life following return to dialysis after transplant failure: The Dialysis Outcomes and Practice Patterns Study. J Perl et al. Nephrology Dialysis Transplantation, 2012.
|
|
|
|
|
